It was noted that expression of stem cell surface biomarkers, e.g., CD133, CD44, CD24, and CD117, is associated with metastasis to lymph nodes, poor prognosis, and resistance to chemo/radiotherapy in patients with HNSCC [76,79,83,86]. This evidence concerns the gene KIT and head and neck squamous cell carcinoma.